# EDGAR Filing Document

**Accession Number:** 0001224133
**File Stem:** 0001193125-25-215414
**Filing Date:** 2025-9
**Character Count:** 11280
**Document Hash:** 5f5836c1d401750203ede1c62629143b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-215414.hdr.sgml**: 20250924

**ACCESSION NUMBER**: 0001193125-25-215414

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250915

**FILED AS OF DATE**: 20250924

**DATE AS OF CHANGE**: 20250924

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Feeney Francis J
- **CENTRAL INDEX KEY:** 0002087473

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-50658
- **FILM NUMBER:** 251338398

**MAIL ADDRESS:**
- **STREET 1:** C/O MARCHEX, INC.
- **STREET 2:** 1200 5TH AVE, SUITE 1300
- **CITY:** SEATTLE
- **STATE:** WA
- **ZIP:** 98101
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MARCHEX INC
- **CENTRAL INDEX KEY:** 0001224133
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-BUSINESS SERVICES, NEC [7389]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 352194038
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 1200 FIFTH AVE
- **STREET 2:** SUITE 1300
- **CITY:** SEATTLE
- **STATE:** WA
- **ZIP:** 98101
- **BUSINESS PHONE:** 206-331-3300

**MAIL ADDRESS:**
- **STREET 1:** 1200 FIFTH AVE
- **STREET 2:** SUITE 1300
- **CITY:** SEATTLE
- **STATE:** WA
- **ZIP:** 98101

## Ex-24

EX-24 DOCUMENT

POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby constitutes and appoints

Brian Nagle of Marchex, Inc. (the "Company") signing singly, and with full power of substitution, the

undersigned's true and lawful attorney-in-fact to:

(1) prepare, execute in the undersigned's name and on the undersigned's behalf,

and submit to the U.S. Securities and Exchange Commission (the "SEC") a Form ID,

including amendments thereto, and any other documents necessary or appropriate

to obtain codes and passwords enabling the undersigned to make electronic

filings with the SEC of reports required by Section 16(a) of the Securities

Exchange Act of 1934 or any rule or regulation of the SEC;

(2) execute for and on behalf of the undersigned, in the undersigned's capacity

as an officer and/or director of the Company, Forms 3, 4, and 5 in accordance

with Section 16(a) of the Securities Exchange Act of 1934 and the rules

thereunder;

(3) do and perform any and all acts for and on behalf of the undersigned which

may be necessary or desirable to complete and execute any such Form 3, 4, or 5,

complete and execute any amendment or amendments thereto, and timely file such

form with the SEC and any stock exchange or similar authority; and

(4) take any other action of any type whatsoever in connection with the

foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,

in the best interest of, or legally required by, the undersigned, it being

understood that the documents executed by such attorney-in-fact on behalf of the

undersigned pursuant to this power of attorney shall be in such form and shall

contain such terms and conditions as such attorney in fact may approve in such

attorney in fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and

authority to do and perform any and every act and thing whatsoever requisite,

necessary, or proper to be done in the exercise of any of the rights and powers

herein granted, as fully to all intents and purposes as the undersigned might or

could do if personally present, with full power of substitution or revocation,

hereby ratifying and confirming all that such attorney-in-fact, or such attorney-

in-fact's substitute or substitutes, shall lawfully do or cause to be done by

virtue of this power of attorney and the rights and powers herein granted. The

undersigned acknowledges that the foregoing attorneys-in-fact, in serving in

such capacity at the request of the undersigned, are not assuming, nor is the

Company assuming, any of the undersigned's responsibilities to comply with

Section 16 of the Securities Exchange Act of 1934.

This power of attorney shall remain in full force and effect until the

undersigned is no longer required to file Forms 3, 4, and 5 with respect to the

undersigned's holdings of and transactions in securities issued by the Company,

unless earlier revoked by the undersigned in a signed writing delivered to the

foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this power of attorney to be

executed as of this 10th day of September 2025.

&nbsp;&nbsp;&nbsp;&nbsp; /s/ Francis J Feeney

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Signature

Francis J Feeney

Print Name

------

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Feeney Francis J<br><sub>(Last) (First) (Middle)</sub><br>1200 5TH AVE<br>SUITE 1300<br><sub>(Street)</sub><br>SEATTLE, WA 98101<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>MARCHEX INC [ MCHX ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2025-09-15 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Chief Operating Officer_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Class B Common Stock | 197428 | D |  |
| Class B Common Stock | 40000<sup>(1)</sup> | D |  |
| Class B Common Stock | 40000<sup>(2)</sup> | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Employee Stock Option (right to buy) | 2022-10-01 | 2028-10-01 | Class B Common Stock | 125000 | $2.82 | D |  |
| Employee Stock Option (right to buy) | 2023-04-17 | 2029-04-17 | Class B Common Stock | 13000 | $5.05 | D |  |
| Employee Stock Option (right to buy) | 2025-01-04 | 2031-01-04 | Class B Common Stock | 30000 | $2.02 | D |  |
| Employee Stock Option (right to buy) | <sup>(3)</sup> | 2032-01-03 | Class B Common Stock | 40000 | $2.56 | D |  |
| Employee Stock Option (right to buy) | <sup>(4)</sup> | 2033-01-03 | Class B Common Stock | 40000 | $1.72 | D |  |
| Employee Stock Option (right to buy) | <sup>(5)</sup> | 2033-09-28 | Class B Common Stock | 300000 | $1.45 | D |  |
| Employee Stock Option (right to buy) | <sup>(6)</sup> | 2034-07-26 | Class B Common Stock | 200000 | $1.58 | D |  |
| Employee Stock Option (right to buy) | <sup>(7)</sup> | 2034-07-26 | Class B Common Stock | 100000 | $1.58 | D |  |
| Restricted Stock Units | <sup>(8)</sup> | <sup>(8)</sup> | Class B Common Stock | 62500 | $0.00 | D |  |

---

### Footnotes:

(1) Restricted stock award effective on the Grant Date, which was January 3, 2022, with 25% of such shares vesting on the first, second, third, and fourth annual anniversary of the Grant Date, subject to Feeney remaining a continuous and full-time active employee.

(2) Restricted stock award effective on the Grant Date, which was January 3, 2023, with 25% of such shares vesting on the first, second, third, and fourth annual anniversary of the Grant Date, subject to Feeney remaining a continuous and full-time active employee.

(3) Stock option award effective on the Grant Date, which was January 3, 2022, with 25% of such option shares vesting on the first annual anniversary of the Grant Date and 1/12 of the remainder vesting in equal increments quarterly thereafter over the following three (3) year period, subject to Feeney remaining a continuous and full-time active employee.

(4) Stock option award effective on the Grant Date, which was January 3, 2023, with 25% of such option shares vesting on the first annual anniversary of the Grant Date and 1/12 of the remainder vesting in equal increments quarterly thereafter over the following three (3) year period, subject to Feeney remaining a continuous and full-time active employee.

(5) Stock option award effective on the Grant Date, which was September 28, 2023, with 25% of such option shares vesting on the first annual anniversary of the Grant Date and 1/12 of the remainder vesting in equal increments quarterly thereafter over the following three (3) year period, subject to Feeney remaining a continuous and full-time active employee.

(6) Stock option award effective on the Grant Date, which was July 26, 2024, with 25% of such option shares vesting on the first annual anniversary of the Grant Date and 1/12 of the remainder vesting in equal increments quarterly thereafter over the following three (3) year period, subject to Feeney remaining a continuous and full-time active employee.

(7) Stock option award effective on the Grant Date, which was July 26, 2024, with such option shares vesting in full on the fourth annual anniversary of the Grant Date, subject to Feeney remaining a continuous and full-time active employee.

(8) Restricted stock units award effective on the Grant Date, which was March 20, 2025. Each restricted stock unit represents the right to receive one share of the Company's Class B Common Stock upon vesting, which occurs in full on the first anniversary of the Grant Date, subject to Feeney remaining a continuous and full-time active employee.

**Remarks:**
Exhibit List: Exhibit 24 (Power of Attorney)

**Signature:** /s/ Francis J Feeney  
**Date:** 2025-09-24

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**